Novo Nordisk launches insulin pen production line in Iran

Novo Nordisk launched an insulin pen production line in Iran, the first of its kind in West Asia and East Mediterranean region. The project involved an investment of €70 million and is expected to create at least 150 jobs, producing up to 25 million insulin pens in the first year.

“Novo Nordisk, a leading global healthcare company, headquartered in Denmark, launched an insulin pen production line in Iran on Monday which is said to be the first of its kind in West Asia and East Mediterranean region.”tehrantimes.com

• 1 source
• tehrantimes.comForeign company invests €70m in Iranian medical project - Tehran TimesAug 31, 2020

Summarized from public sources; check the original articles before acting on it.